Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
ESMO OPEN
Rivista
Codice:
E234758
ISSN:
2059-7029
Dati Generali
Dati Generali
Pubblicazioni (24)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
Articolo
BET bromodomain inhibitor birabresib in mantle cell lymphoma: In vivo activity and identification of novel combinations to overcome adaptive resistance
Articolo
Bratislava Statement: Consensus recommendations for improving pancreatic cancer care
Articolo
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective
Articolo
Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center
Articolo
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
Articolo
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)
Articolo
Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC
Articolo
Corrigendum to “Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center”: [ESMO Open 7 (2022) 100607] (ESMO Open (2022) 7(6), (S205970292200237X), (10.1016/j.esmoop.2022.100607))
Articolo
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
Articolo
Erratum to ‘How we treat primary central nervous system lymphoma’: [ESMO Open Volume 6, Issue 4, August 2021, 100213] (ESMO Open (2021) 6(4), (S2059702921001745), (10.1016/j.esmoop.2021.100213))
Articolo
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
Articolo
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
Articolo
How I treat HER2-positive early breast cancer: how long adjuvant trastuzumab is needed?
Articolo
How we treat primary central nervous system lymphoma
Articolo
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma
Articolo
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
Articolo
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
Articolo
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Articolo
Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib
Articolo
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
Articolo
Second-line treatments: Moving towards an opportunity to improve survival in advanced gastric cancer?
Articolo
Somatic and germline genomic variation in thymic carcinomas
Articolo
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
